ArticleTranslational lung cancer research2025

Endocrine immune-related adverse events in advanced lung cancer patients receiving immune checkpoint inhibitors: incidence, predictors and outcomes.

Yi Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.